Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical unit Tanabe Mitsubishi Pharma to U.S. private equity ...
Mitsubishi Chemical Group has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a bid to focus on its key chemical businesses. The Japanese chemical company said ...
The Japanese stock market is trading sharply higher on Tuesday, reversing the sharp losses in the previous session, despite the ...
The Japanese stock market is sharply higher on Monday, snapping the three-session winning streak, following the broadly negative cues ...
Arabian Post on MSN1d
Bain Capital Nears Acquisition of Mitsubishi’s Pharma Division in $3.2 Billion DealDubai Bain Capital is in the final stages of negotiations to acquire Mitsubishi Chemical Group's pharmaceutical subsidiary, ...
Cryogenic Fuels Market Worth USD 188.7 billion by 2030 Development of carbon capture technologies, increasing number of M&A act ...
Mitsubishi Gas Chemical Company, Inc. (MGC), a Japanese methanol manufacturer and supplier for chemical and energy sectors including Methanol-to-Hydrogen applications, Methanol Reformer S.L., a ...
Bain Capital is nearing a deal to buy Mitsubishi Chemical Group Corp.’s pharmaceutical unit, people familiar with the matter ...
The investment firm is acquiring Mitsubishi Tanabe Pharma in a deal valued at $3.3 billion. Elsewhere, Bausch + Lomb hasn’t ...
Bain Capital has agreed to acquire Tanabe Pharma, the pharma arm of Mitsubishi Chemical Group Corporation. The deal puts Tanabe Pharma at a valuation of about $3.3 billion. Founded in 1678, Tanabe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback